Oral Antibiotics Preferred for Pediatric Pneumonia
By Daniel Beris Posted on 30 Nov 2016 |

Image: Research shows oral antibiotics following pneumonia in children show good results (Photo courtesy of Masterfile).
Children with complicated pneumonia should be discharged from the hospital with oral instead of intravenous (IV) antibiotics when possible, according to a new study.
Researchers at Cincinnati Children's Hospital (OH, USA), the University of Pennsylvania (PA, USA), and other institutions conducted a multicenter retrospective cohort study of data from the Pediatric Health Information System (PHIS) to compare effectiveness and treatment-related complications of post-discharge antibiotics administered via a peripherally inserted central venous catheter (PICC), or administered orally. The study included 2,123 children from 36 hospitals who received oral (1,842) and PICC (281) antibiotics that were discharged with complicated pneumonia between 2009 and 2012.
The results showed no significant differences in treatment failure rates between PICC and oral antibiotics. Conversely, children discharged with PICCs experienced a higher rate of infections, adverse drug reactions, and hospital readmissions, with PICC complications occurring in 7.1% of children who received intravenous antibiotics. In addition, 17.8% of the children who received IV antibiotics required unplanned or emergency care, compared with only 3.1% of children who received oral antibiotics. The study was published on November 17, 2016, in Pediatrics.
“Children with complicated pneumonia typically require prolonged antibiotic therapy, 2 to 4 weeks in total, much of which is administered after hospital discharge. Our study demonstrates that oral antibiotics are just as effective as intravenous antibiotics, but with fewer treatment-associated complications,” said lead author Samir Shah, MD, of Cincinnati Children's Hospital. “This means that most children with complicated pneumonia can safely be discharged with antibiotics by mouth, avoiding the pain and potential complications associated with PICC lines.”
“One other factor to consider is that some antibiotics such as vancomycin can only be given by PICC. It is possible that the higher rate of adverse drug reactions in the PICC group, such as drug fever or low blood counts, were related to type of antibiotic used, rather than how it was given,” concluded Dr. Shah. “The reality is that one should consider the higher rate of adverse drug reactions in the PICC group, regardless of the reason, as one more factor favoring the use of antibiotics by mouth for complicated pneumonia.”
Related Links:
Cincinnati Children's Hospital
University of Pennsylvania
Researchers at Cincinnati Children's Hospital (OH, USA), the University of Pennsylvania (PA, USA), and other institutions conducted a multicenter retrospective cohort study of data from the Pediatric Health Information System (PHIS) to compare effectiveness and treatment-related complications of post-discharge antibiotics administered via a peripherally inserted central venous catheter (PICC), or administered orally. The study included 2,123 children from 36 hospitals who received oral (1,842) and PICC (281) antibiotics that were discharged with complicated pneumonia between 2009 and 2012.
The results showed no significant differences in treatment failure rates between PICC and oral antibiotics. Conversely, children discharged with PICCs experienced a higher rate of infections, adverse drug reactions, and hospital readmissions, with PICC complications occurring in 7.1% of children who received intravenous antibiotics. In addition, 17.8% of the children who received IV antibiotics required unplanned or emergency care, compared with only 3.1% of children who received oral antibiotics. The study was published on November 17, 2016, in Pediatrics.
“Children with complicated pneumonia typically require prolonged antibiotic therapy, 2 to 4 weeks in total, much of which is administered after hospital discharge. Our study demonstrates that oral antibiotics are just as effective as intravenous antibiotics, but with fewer treatment-associated complications,” said lead author Samir Shah, MD, of Cincinnati Children's Hospital. “This means that most children with complicated pneumonia can safely be discharged with antibiotics by mouth, avoiding the pain and potential complications associated with PICC lines.”
“One other factor to consider is that some antibiotics such as vancomycin can only be given by PICC. It is possible that the higher rate of adverse drug reactions in the PICC group, such as drug fever or low blood counts, were related to type of antibiotic used, rather than how it was given,” concluded Dr. Shah. “The reality is that one should consider the higher rate of adverse drug reactions in the PICC group, regardless of the reason, as one more factor favoring the use of antibiotics by mouth for complicated pneumonia.”
Related Links:
Cincinnati Children's Hospital
University of Pennsylvania
Latest Critical Care News
- Novel Cannula Delivery System Enables Targeted Delivery of Imaging Agents and Drugs
- Ingestible Smart Capsule for Chemical Sensing in the Gut Moves Closer to Market
- Novel Intrabronchial Method Delivers Cell Therapies in Critically Ill Patients on External Lung Support
- Generative AI Technology Detects Heart Disease Earlier Than Conventional Methods
- Wearable Technology Predicts Cardiovascular Risk by Continuously Monitoring Heart Rate Recovery
- Wearable Health Monitoring Device Measures Gases Emitted from and Absorbed by Skin
- Groundbreaking Technology Rapidly Detects Airborne Influenza Viruses
- Handheld Device Could Transform Heart Disease Screening
- Flexible Semi-Autonomous Robot Could Deliver Medicine Inside Body
- Neurorestorative Treatment Strategies Hold Promise for Most Severe Forms of Epilepsy
- Gene Discovery Could Help Grow New Heart Arteries
- Study Discovers Invisible Transmission of Common Hospital-Associated Infection
- Non-Invasive Neuro-Ophthalmology Techniques Could Detect Brain Tumors Earlier
- Mass Manufactured Nanoparticles to Deliver Cancer Drugs Directly to Tumors
- World’s Smallest Pacemaker Fits Inside Syringe Tip
- AI-Powered, Internet-Connected Medical Devices to Revolutionize Healthcare, Finds Study
Channels
Surgical Techniques
view channel
Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures
In patients with coronary artery disease, certain blood vessels may be narrowed or blocked, requiring a stent or a bypass (also known as diversion) to restore blood flow to the heart. Bypass surgeries... Read more
Intravascular Imaging for Guiding Stent Implantation Ensures Safer Stenting Procedures
Patients diagnosed with coronary artery disease, which is caused by plaque accumulation within the arteries leading to chest pain, shortness of breath, and potential heart attacks, frequently undergo percutaneous... Read more
World's First AI Surgical Guidance Platform Allows Surgeons to Measure Success in Real-Time
Surgeons have always faced challenges in measuring their progress toward surgical goals during procedures. Traditionally, obtaining measurements required stepping out of the sterile environment to perform... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Expanded Collaboration to Transform OR Technology Through AI and Automation
The expansion of an existing collaboration between three leading companies aims to develop artificial intelligence (AI)-driven solutions for smart operating rooms with sophisticated monitoring and automation.... Read more